Get started
Work

OA06.02 Safety and Efficacy of QLC5508 in Previously Treated Patients with Small Cell Lung Cancer: Updated Data from a Phase 1 Study

Year: 2025
Type: conference-abstract
DOI: 10.1016/j.jtho.2025.09.047
Authors: C. Zhou, Y. Yu, X. Yu, Y. Sun, X. Meng, Y. Ji, F. Ning, Y. Jia, Y. Ji, H. Yang, Y. Luo, R. Yang, Z. Zhang, Y. Zhao, Z. Zhang, Q. Wen, M. Sun, L. Shen, L. Han, Z. Zhang, O. Jiang, G. Wu, X. Wang, L. Wan, G. Cao, H. Li, W. Cheng, X. Qiu, X. Kang
Institutions: Tongji University, Shanghai Pulmonary Hospital, Shanghai East Hospital, Third Affiliated Hospital of Harbin Medical University, Zhejiang Cancer Hospital, Shandong Tumor Hospital, First Affiliated Hospital of Xinxiang Medical University, Anyang Tumor Hospital, Binzhou Medical University, Second People’s Hospital of Yibin, Hunan Cancer Hospital, First Affiliated Hospital of Henan University of Science and Technology, The First People's Hospital of Neijiang, First People's Hospital of Xianyang, Henan Cancer Hospital, Shandong First Medical University, Peking University Cancer Hospital, Xuzhou Central Hospital, Second Hospital of Nanchang, First Affiliated Hospital of Gannan Medical University, Qilu Pharmaceutical Co., Ltd. (China)
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4415520179
Cites:
Cited by: 2
Related to: